| Page 19 | Cafepharma

You are here

Primary tabs

Catabasis Pharmaceuticals' Edasalonexent Slowed Duchenne Muscular Dystrophy Disease Progression Through One Year of Treatment

Post date: April 25, 2018 - 7:39pm

Canadian STEMCELL Technologies Receives $45 Million Government Funding for Advanced Manufacturing Facility

Post date: April 25, 2018 - 4:47pm

Is Vaxart One to Watch...Maybe?

Post date: April 25, 2018 - 1:59pm

First Patient Dosed in Avexis' Phase 3 Trial of AVXS-101 in Pre-Symptomatic Spinal Muscular Atrophy

Post date: April 25, 2018 - 9:46am

OrphoMed's IBS-D Candidate ORP-101 Receives Fast Track Designation

Post date: April 25, 2018 - 9:18am

AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study

Post date: April 25, 2018 - 9:07am

New Data For Alder BioPharmaceuticals' Eptinezumab Shows Long-Term Reduction in Episodic Migraine

Post date: April 24, 2018 - 11:52pm

Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials

Post date: April 24, 2018 - 11:17pm

Interview With Hatch-Waxman Expert Kurt Karst

Post date: April 24, 2018 - 7:50pm

Overview of Pfizer's Biosimilar Program

Post date: April 24, 2018 - 7:43pm

Pages